Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nektium’s branded botanical extracts—including Zynamite®, Rhodiolife®, and Xanthigen®—are supported by preclinical and clinical studies demonstrating benefits in cognitive function, physical performance, stress adaptation, and weight management. Their flagship ingredient Zynamite® has won industry awards for its research-backed efficacy.[1][5] The company collaborates with academic institutions for clinical validation of its products.[1]
No pharmaceutical drug development or regulatory approval stages; all offerings are commercial nutraceutical ingredients.Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nektium.